KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Outstanding
Ratios

Biogen (BIIB) Receivables - Other (2018 - 2023)

Biogen has reported Receivables - Other over the past 9 years, most recently at $6.3 million for Q1 2023.

  • For Q1 2023, Receivables - Other rose 8.62% year-over-year to $6.3 million; the TTM value through Mar 2023 reached $6.3 million, up 8.62%, while the annual FY2022 figure was $2.0 million, 51.22% down from the prior year.
  • Receivables - Other for Q1 2023 was $6.3 million at Biogen, up from $2.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $85.0 million in Q4 2019 and troughed at $1.8 million in Q3 2022.
  • A 5-year average of $12.2 million and a median of $4.3 million in 2020 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: plummeted 94.0% in 2020 and later grew 8.62% in 2023.
  • Year by year, Receivables - Other stood at $85.0 million in 2019, then plummeted by 94.0% to $5.1 million in 2020, then decreased by 19.61% to $4.1 million in 2021, then tumbled by 51.22% to $2.0 million in 2022, then soared by 215.0% to $6.3 million in 2023.
  • Business Quant data shows Receivables - Other for BIIB at $6.3 million in Q1 2023, $2.0 million in Q4 2022, and $1.8 million in Q3 2022.